Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus
Go back to Emergent BioSolutions (EBS) Tops Q4 EPS by 4c, Beats on Revenues; Offers FY18 Revenues Above Consensus| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 7.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.02 | 52 Week High | $44.38 | |||
| Open | $6.84 | 52 Week Low | $24.47 | |||
| Day High | $7.05 | P/E | 351.00 | |||
| Day Low | $6.80 | EPS | $0.02 | |||
| Volume | 3 | |||||
